CFDE Data Portal | Search LINC02550

	Label	Description
	LINC02550 Gene (Entity type)	ENSG00000271584 - long intergenic non-protein coding RNA 2550
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155162 GSE155169 buparlisib 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE142357 HDAC3 inhibition 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE214931 temozolomide 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02550

ENSG00000271584 - long intergenic non-protein coding RNA 2550

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE155162 GSE155169 buparlisib 1 v 3 human dn

A Gene Set from LINCS

GSE195663 cisplatin 0 v 3 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 7 human dn

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE228106 paclitaxel R1192 0 v 4 human up

A Gene Set from LINCS

GSE142357 HDAC3 inhibition 1 v 3 human dn

A Gene Set from LINCS

GSE195663 cisplatin 7 v 3 human dn

A Gene Set from LINCS

GSE214931 temozolomide 2 v 5 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.